Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer

This study provides genetic evidence supporting the causal roles of specific immune cell phenotypes, particularly CD38<sup>+</sup>CD20<sup>-</sup> B cells, CD33<sup>+</sup>CD14<sup>+</sup> monocytes, and CD45⁺CD33⁺HLA-DR<sup>+</sup>CD14dim myeloid cells, in promoting EC risk. Furthermore, we identified the aspartate to citrate ratio as a significant metabolic mediator in the pathway linking monocyte activity to esophageal carcinogenesis. These findings unveil a novel immunometabolic axis and highlight potential therapeutic targets for intervening in EC development.

Authors

Institutions

Publication Details

Journal
Journal of Gastrointestinal Oncology
Published
2025-10-01
DOI
https://doi.org/10.21037/jgo-2025-774
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer

Dorina Gui, Wenhua Liang, Si‐Min Lu, Kaichun Wu et al.
Journal of Gastrointestinal Oncology
Immune cells in cancer
article

Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer

Dorina Gui, Wenhua Liang, Si‐Min Lu, Kaichun Wu, Siyu Guo, Yi Feng, Shubin Wang, Zhengyang Yan, Hui Sun, Jingxun Wu, Xuan Wu, Hehui Wang
article en

Abstract

This study provides genetic evidence supporting the causal roles of specific immune cell phenotypes, particularly CD38<sup>+</sup>CD20<sup>-</sup> B cells, CD33<sup>+</sup>CD14<sup>+</sup> monocytes, and CD45⁺CD33⁺HLA-DR<sup>+</sup>CD14dim myeloid cells, in promoting EC risk. Furthermore, we identified the aspartate to citrate ratio as a significant metabolic mediator in the pathway linking monocyte activity to esophageal carcinogenesis. These findings unveil a novel immunometabolic axis and highlight potential therapeutic targets for intervening in EC development.

Journal of Gastrointestinal OncologyVol. 16(5)
Guangdong Medical College (CN), Shenzhen University (CN), Shantou University (CN), First Affiliated Hospital of Xiamen University (CN), First Affiliated Hospital of Guangzhou Medical University (CN), Shantou University Medical College (CN), Peking University Shenzhen Hospital (CN), State Key Laboratory of Respiratory Disease (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 67%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer — Dorina Gui, Wenhua Liang, et al. · Journal of Gastrointestinal Oncology (2025) | TGRS Research Map | TGRS